Free Trial

Geneos Wealth Management Inc. Buys 3,268 Shares of Cameco Corporation $CCJ

Cameco logo with Basic Materials background

Key Points

  • Geneos Wealth Management Inc. increased its stake in Cameco Corporation by 37.3%, acquiring 3,268 additional shares and bringing its total holdings to 12,026 shares valued at approximately $495,000.
  • Institutional investors now own 70.21% of Cameco's stock, highlighting significant interest from larger funds, including Manchester Capital Management which doubled its investment.
  • Analysts have a consensus rating of "Buy" for Cameco, with price targets ranging from $65.00 to $102.00, as the company recently reported a quarterly EPS of $0.51, exceeding estimates.
  • MarketBeat previews top five stocks to own in October.

Geneos Wealth Management Inc. boosted its holdings in Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO by 37.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,026 shares of the basic materials company's stock after purchasing an additional 3,268 shares during the period. Geneos Wealth Management Inc.'s holdings in Cameco were worth $495,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Manchester Capital Management LLC lifted its stake in Cameco by 100.0% in the first quarter. Manchester Capital Management LLC now owns 600 shares of the basic materials company's stock valued at $25,000 after acquiring an additional 300 shares during the last quarter. Dagco Inc. acquired a new stake in Cameco in the first quarter valued at $28,000. SVB Wealth LLC acquired a new stake in Cameco in the first quarter valued at $29,000. Copia Wealth Management acquired a new stake in Cameco in the fourth quarter valued at $39,000. Finally, Ameriflex Group Inc. acquired a new stake in Cameco in the fourth quarter valued at $40,000. Institutional investors own 70.21% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on CCJ shares. UBS Group set a $102.00 target price on shares of Cameco in a research note on Tuesday, September 9th. The Goldman Sachs Group lifted their price objective on shares of Cameco from $65.00 to $78.00 and gave the stock a "buy" rating in a research note on Wednesday, June 11th. CLSA assumed coverage on shares of Cameco in a research note on Tuesday, September 9th. They issued an "outperform" rating and a $102.00 price objective for the company. Wall Street Zen cut shares of Cameco from a "buy" rating to a "hold" rating in a research note on Monday. Finally, National Bankshares reiterated an "outperform" rating on shares of Cameco in a research note on Friday, August 22nd. Two equities research analysts have rated the stock with a Strong Buy rating and thirteen have issued a Buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $89.55.

Check Out Our Latest Stock Analysis on Cameco

Cameco Price Performance

CCJ stock opened at $78.07 on Monday. The company has a quick ratio of 2.00, a current ratio of 2.96 and a debt-to-equity ratio of 0.15. Cameco Corporation has a 12 month low of $35.00 and a 12 month high of $83.02. The firm has a market cap of $33.99 billion, a P/E ratio of 89.74 and a beta of 1.04. The company's 50-day moving average price is $76.21 and its two-hundred day moving average price is $60.12.

Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last released its earnings results on Thursday, July 31st. The basic materials company reported $0.51 EPS for the quarter, beating the consensus estimate of $0.29 by $0.22. Cameco had a net margin of 14.97% and a return on equity of 8.21%. The firm had revenue of $467.72 million for the quarter, compared to analyst estimates of $819.79 million. During the same period last year, the firm earned $0.14 EPS. The business's quarterly revenue was up 46.7% compared to the same quarter last year. Cameco has set its FY 2025 guidance at EPS. On average, analysts anticipate that Cameco Corporation will post 1.27 earnings per share for the current fiscal year.

About Cameco

(Free Report)

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.

Recommended Stories

Institutional Ownership by Quarter for Cameco (NYSE:CCJ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cameco Right Now?

Before you consider Cameco, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cameco wasn't on the list.

While Cameco currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Biotech Stocks Under $5 With Huge Upside
Revealed: Congress’ Biggest Stock Moves This Month
He Said Sell Oracle. Here’s What Happened Next.

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines